Management of Hypertensive Urgency
For patients with hypertensive urgency (BP >180/120 mmHg WITHOUT acute target organ damage), initiate oral antihypertensive therapy and arrange outpatient follow-up within 2-4 weeks—avoid IV medications and rapid BP reduction, as these may cause harm. 1
Critical First Step: Distinguish Emergency from Urgency
The presence or absence of acute target organ damage—not the BP number itself—determines management 1, 2:
- Hypertensive urgency: Severe BP elevation WITHOUT acute organ damage → oral medications, outpatient management 1
- Hypertensive emergency: Severe BP elevation WITH acute organ damage → ICU admission, IV therapy 3, 2
Assess for Target Organ Damage
Perform focused evaluation for 1, 2:
- Neurologic: Altered mental status, headache with vomiting, visual disturbances, seizures, focal deficits 1
- Cardiac: Chest pain, acute MI, pulmonary edema 1
- Renal: Acute kidney injury, oliguria 1
- Ophthalmologic: Bilateral retinal hemorrhages, cotton wool spots, papilledema on fundoscopy (malignant hypertension) 1, 2
- Vascular: Signs of aortic dissection 1
If ANY acute target organ damage is present, this is a hypertensive emergency requiring immediate ICU admission and IV therapy—not hypertensive urgency. 1, 2
Management of Confirmed Hypertensive Urgency
Blood Pressure Reduction Goals
- Reduce SBP by no more than 25% within the first hour 1
- Then aim for BP <160/100 mmHg over the next 2-6 hours if stable 1
- Cautiously normalize BP over 24-48 hours 1
Avoid rapid BP lowering—this may precipitate cerebral, renal, or coronary ischemia, particularly in patients with chronic hypertension who have altered autoregulation. 3, 1
First-Line Oral Medications
The European Society of Cardiology and American College of Cardiology recommend three preferred agents 1:
Captopril (ACE inhibitor): Start at very low doses due to risk of sudden BP drops in volume-depleted patients (from pressure natriuresis) 1
Labetalol (combined alpha and beta-blocker): Dual mechanism provides controlled BP reduction 1
Extended-release nifedipine (calcium channel blocker): Use ONLY extended-release formulation 1
Critical Medication Contraindications
NEVER use short-acting nifedipine—it causes unpredictable, rapid BP drops that can precipitate stroke and death. 1
Avoid IV medications for hypertensive urgency—these are reserved exclusively for hypertensive emergencies with acute target organ damage. 1
Observation and Monitoring
- Observe for at least 2 hours after initiating oral medication to evaluate BP-lowering efficacy and safety 1
- Monitor for signs of organ hypoperfusion: new chest pain, altered mental status, acute kidney injury 1
Special Situations
Cocaine or Amphetamine Intoxication
- Initiate benzodiazepines FIRST 3, 1
- If additional BP control needed after benzodiazepines, consider phentolamine, nicardipine, or nitroprusside 1
- Avoid beta-blockers in sympathomimetic-induced hypertension 1
Clonidine Use
Clonidine is NOT first-line for hypertensive urgency 1:
- Reserved for specific situations: autonomic hyperreactivity from cocaine/amphetamine intoxication (after benzodiazepines) or failure of first-line agents 1
- Avoid in older adults due to significant CNS adverse effects including cognitive impairment 1
- Abrupt discontinuation can induce hypertensive crisis—must be tapered carefully 1
Disposition and Follow-Up
Discharge Criteria
Patients with hypertensive urgency can be discharged even if BP remains >180/110 mmHg IF 1:
- No evidence of acute target organ damage 1
- Oral antihypertensive therapy initiated or adjusted 1
- Reliable outpatient follow-up arranged 1
Follow-Up Plan
- Arrange follow-up within 2-4 weeks 1
- Target BP <130/80 mmHg (or <140/90 mmHg in elderly/frail patients) 1
- Address medication non-adherence—the most common trigger for hypertensive urgencies 1
- Schedule at least monthly follow-up until target BP reached 1
Long-Term Considerations
- Up to one-third of patients with elevated BP normalize before follow-up 1
- Patients with previous hypertensive urgency remain at increased cardiovascular and renal risk 1
- Screen for secondary hypertension after stabilization, as 20-40% of malignant hypertension cases have identifiable causes 1, 2
Common Pitfalls to Avoid
Do NOT treat asymptomatic severe hypertension as an emergency—most patients have urgency, not emergency, and aggressive IV treatment can cause harm 1
Do NOT use IV antihypertensives for hypertensive urgency—21-34% of medical inpatients inappropriately receive IV BP medications despite lack of evidence for benefit 1
Do NOT rapidly lower BP in asymptomatic patients—this may cause cerebral, renal, or coronary ischemia 1
Do NOT admit patients with asymptomatic hypertension without evidence of acute target organ damage 1
Do NOT confuse transient BP elevations from acute pain or distress with true hypertensive urgency—many normalize when the underlying condition is treated 1